| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
112,320,000 |
| Market
Cap: |
48.31(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4301 - $0.4301 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avalo Therapeutics is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology and rare genetic diseases. Co.'s clinical-stage pipeline include: AVTX-002, which is developing for the treatment of non-eosinophilic asthma, inflammatory bowel disease; AVTX-007, which is developing AVTX-007 for the treatment of Still's Disease; AVTX-801, which is a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency; and AVTX-803, which is a L-fucose substrate replacement therapy for the treatment of LADII.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
37,351 |
662,763 |
| Total Buy Value |
$0 |
$0 |
$139,843 |
$643,635 |
| Total People Bought |
0 |
0 |
3 |
4 |
| Total Buy Transactions |
0 |
0 |
10 |
32 |
| Total Shares Sold |
0 |
0 |
5,291,542 |
5,291,542 |
| Total Sell Value |
$0 |
$0 |
$3,199,077 |
$3,199,077 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
4 |
4 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boyd Steven |
Director |
– • • |
2018-09-26 |
4 |
B |
$4.63 |
$21,419 |
D/D |
4,631 |
17,493,927 |
3.92 |
- |
|
| Crutcher Patrick J |
VP, Business Development |
• – – |
2018-09-25 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,641,642 |
1,641,642 |
|
- |
|
| Boyd Steven |
Director |
– • • |
2018-09-25 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
17,489,296 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-09-25 |
4 |
B |
$4.60 |
$42,749 |
D/D |
9,296 |
17,489,296 |
3.92 |
- |
|
| Crutcher Patrick J |
VP, Business Development |
• – – |
2018-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,645,286 |
1,645,286 |
|
- |
|
| Boyd Steven |
Director |
– • • |
2018-08-17 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
17,480,000 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-08-17 |
4 |
B |
$3.91 |
$3,910,000 |
D/D |
1,000,000 |
17,480,000 |
3.92 |
- |
|
| Jones Randal |
10% Owner |
– – • |
2018-08-13 |
4 |
S |
$3.98 |
$5,055 |
D/D |
(1,270) |
0 |
|
- |
|
| Jones Randal |
10% Owner |
– – • |
2018-08-13 |
4 |
OE |
$3.20 |
$4,064 |
D/D |
1,270 |
1,270 |
|
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-31 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,480,000 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-31 |
4 |
B |
$4.21 |
$2,757 |
D/D |
655 |
16,480,000 |
3.84 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-30 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,479,345 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-30 |
4 |
B |
$4.26 |
$9,377 |
D/D |
2,200 |
16,479,345 |
3.84 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-27 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,477,145 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-27 |
4 |
B |
$4.41 |
$75,871 |
D/D |
17,145 |
16,477,145 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-26 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,460,000 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-26 |
4 |
B |
$4.48 |
$18,301 |
D/D |
4,081 |
16,460,000 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-25 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,455,919 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-25 |
4 |
B |
$4.34 |
$33,404 |
D/D |
7,700 |
16,455,919 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-18 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,448,219 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-18 |
4 |
B |
$4.35 |
$10,866 |
D/D |
2,500 |
16,448,219 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-17 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,445,719 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-17 |
4 |
B |
$4.30 |
$41,774 |
D/D |
9,719 |
16,445,719 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-16 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,436,000 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-07-16 |
4 |
B |
$4.25 |
$75,765 |
D/D |
17,800 |
16,436,000 |
3.92 |
- |
|
440 Records found
|
|
Page 12 of 18 |
|
|
